Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

After washing the affected area, the wart should be soaked in comfortably warm water for 5 minutes. Following this, the area must be dried thoroughly. One drop of gel should be applied at a time to ensure sufficient coverage of each wart. The gel should be allowed to dry completely.

This procedure should be repeated once or twice daily until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

• Application on moles, birthmarks, and warts with hair growing from them is prohibited due to the potential for adverse effects.

• The product should not be applied to mucous membranes, including the nose, anus, genitals, and lips, to avoid irritation and complications.

• Avoid use on irritated, infected, or reddened skin, as this may exacerbate the condition.

• The product is contraindicated for genital warts and warts located on the face to prevent further irritation and complications.

• Use is not recommended in individuals with diabetes or poor blood circulation unless under the guidance and supervision of a healthcare professional, due to increased risk of complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire and flame to prevent any risk of ignition.

The product should not be applied to moles, birthmarks, or warts that have hair growing from them. It is contraindicated for use on mucous membranes, including the nose, anus, genitals, and lips. Additionally, it should not be used on irritated, infected, or reddened skin, nor on genital warts or warts located on the face. Patients with diabetes or poor blood circulation should only use this product under the advice and supervision of a qualified healthcare professional, such as a doctor or podiatrist.

When using this product, if it comes into contact with the eyes, it is imperative to flush the eyes with water for at least 15 minutes. Users should also avoid inhaling vapors to minimize respiratory irritation.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

If discomfort persists after application, it is advised to consult a healthcare professional, such as a doctor or podiatrist, for further evaluation and management.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it should be kept away from fire and flame. The product should not be used on moles, birthmarks, or warts with hair growing from them, nor should it be applied to mucous membranes such as the nose, anus, genitals, and lips. Additionally, it is contraindicated for use on irritated, infected, or reddened skin, as well as on genital warts and warts on the face. Patients who are diabetic or have poor blood circulation should only use this product under the advice and supervision of a doctor or podiatrist.

During the use of this product, if it comes into contact with the eyes, it is important to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors associated with the product.

This product should be kept out of reach of children. In the event of accidental ingestion, it is crucial to seek medical help or contact a Poison Control Center immediately. If discomfort persists after use, patients are advised to consult their doctor or podiatrist for further evaluation.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover gel tube). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The safety of Salicylic Acid wart remover gel during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in pregnant patients. There are no documented safety concerns, dosage modifications, or special precautions outlined for this population. Given the lack of information, healthcare professionals are advised to exercise caution when considering the use of this product in women of childbearing potential. It is recommended that pregnant patients consult their healthcare provider before using Salicylic Acid wart remover gel to discuss potential risks and benefits.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further data may be necessary to inform clinical decisions.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment as necessary. It is recommended that healthcare providers follow established protocols for the management of overdosage, which may involve the administration of activated charcoal, intravenous fluids, or other interventions based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of a Poison Control Center can provide valuable guidance on the appropriate management strategies tailored to the specific circumstances of the case.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that this product is not intended for use on moles, birthmarks, or warts with hair growing from them. Additionally, it should not be applied to mucous membranes, including the nose, anus, genitals, and lips. Healthcare providers should emphasize that the product must not be used on irritated, infected, or reddened skin, nor on genital warts or warts located on the face.

It is crucial to inform patients that individuals who are diabetic or have poor blood circulation should not use this product unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist.

Patients should be instructed to flush their eyes with water for 15 minutes if the product accidentally gets into their eyes. Furthermore, they should avoid inhaling vapors while using the product. If discomfort persists after application, patients are encouraged to consult their doctor or podiatrist for further evaluation and guidance.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to store the product in a controlled environment, maintaining a temperature range between 59°F to 86°F (15°C to 30°C).

Care should be taken to keep the product away from fire and flame to ensure safety and integrity. Proper storage conditions are crucial for maintaining the quality and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)